What is precision medicine, and how is it different from standard treatment

Precision Medicine vs. Standard Treatment

What is Precision Medicine?

Precision medicine (also called personalized medicine) is an approach where treatment decisions are tailored to the individual characteristics of each patient's cancer, rather than using a one-size-fits-all approach.

Instead of treating all patients with the same cancer type identically, precision medicine uses information about:

• Genetic mutations in the tumor (like EGFR, BRAF, PD-L1)
• Biomarkers (protein or genetic signatures that predict treatment response)
• Tumor characteristics (hormone receptor status, HER2 status)
• Patient factors (age, kidney/liver function, other health conditions)

This information helps oncologists select treatments most likely to work for that specific patient's cancer.

Key Differences from Standard Treatment

| Standard Treatment | Precision Medicine | |---|---| | Same treatment for all patients with same cancer type | Treatment selected based on tumor's genetic profile | | Based on cancer location and stage | Based on what makes each tumor unique | | "Try this, see if it works" approach | "This mutation responds to this drug" approach | | May include unnecessary treatments | Focuses on treatments likely to be effective |

Real-World Example

Standard approach: All patients with advanced lung cancer get chemotherapy.

Precision medicine approach:

• Patient A has an EGFR mutation → gets targeted therapy (like erlotinib)
• Patient B has a PD-L1 high tumor → gets immunotherapy (like pembrolizumab)
• Patient C has no specific mutations → may get chemotherapy

How This Helps You

According to NCCN Guidelines and ASCO recommendations, precision medicine can:

• Improve response rates - treatments work better when matched to the tumor
• Reduce side effects - avoid drugs unlikely to help
• Extend survival - targeted therapies often outperform standard chemotherapy for specific mutations
• Guide clinical trial eligibility - many trials require specific biomarkers

What Testing is Involved?

Your oncologist may order:

• Tumor genetic testing (sequencing the cancer cells)
• Immunotherapy biomarkers (PD-L1, tumor mutational burden)
• Hormone receptor testing (ER/PR, HER2 status)
• Blood tests (circulating tumor DNA, other markers)

Questions to Ask Your Doctor

1. "Has my tumor been tested for genetic mutations or biomarkers?"
2. "Are there specific mutations in my cancer that would guide treatment selection?"
3. "Are there targeted therapies or immunotherapies available for my tumor's profile?"
4. "What testing do you recommend, and how will results change my treatment plan?"
5. "Are there clinical trials available for my specific mutation or biomarker?"

Important Context

Precision medicine is becoming standard practice. The National Cancer Institute (NCI) and American Cancer Society increasingly emphasize biomarker testing as part of routine cancer care. However, not all cancers have identified "actionable" mutations yet, and some patients may not have specific mutations that match available targeted drugs.

Your oncologist will determine which tests make sense for your specific cancer type and stage.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.